We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBAC.WS
1201
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$4.71M 0.01%
470,000
SAFE
1202
DELISTED
Safehold Inc.
SAFE
$4.71M 0.01%
+164,486
New +$4.68M
NIO icon
1203
NIO
NIO
$11.6B
$4.71M 0.01%
482,617
-2,736,084
-85% -$31.5M
CS
1204
DELISTED
Credit Suisse Group
CS
$4.71M 0.01%
+1,547,788
New +$6.02M
AVGO icon
1205
CALL
Broadcom
AVGO
$1.82T
$4.7M 0.01%
84,000
-128,000
-60% -$6.42M
SAM icon
1206
Boston Beer
SAM
$1.91B
$4.68M 0.01%
+14,203
New +$5.15M
BTMWW
1207
CALL
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$4.67M 0.01%
460,752
SUMO
1208
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$4.67M 0.01%
575,973
+307,786
+115% +$2.34M
AMD icon
1209
CALL
Advanced Micro Devices
AMD
$807B
$4.65M 0.01%
71,800
-806,800
-92% -$53.3M
UMC icon
1210
United Microelectronic
UMC
$47.9B
$4.64M 0.01%
710,577
-308,596
-30% -$2.04M
THO icon
1211
Thor Industries
THO
$3.98B
$4.64M 0.01%
61,432
-226,453
-79% -$18.2M
SCUA
1212
DELISTED
Sculptor Acquisition Corp I
SCUA
$4.63M 0.01%
451,670
LNZA icon
1213
LanzaTech
LNZA
$61.1M
$4.62M 0.01%
4,632
YELL
1214
DELISTED
Yellow Corporation Common Stock
YELL
$4.62M 0.01%
1,840,760
+147,475
+9% +$525K
SBGI icon
1215
Sinclair Inc
SBGI
$974M
$4.61M 0.01%
297,107
-547,950
-65% -$9.75M
BPACW
1216
CALL
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$4.61M 0.01%
450,000
BWA icon
1217
BorgWarner
BWA
$13.1B
$4.6M 0.01%
129,961
+76,500
+143% +$2.6M
UTAA
1218
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$4.59M 0.01%
449,998
EBAC
1219
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$4.59M 0.01%
453,992
BMY icon
1220
Bristol-Myers Squibb
BMY
$128B
$4.58M 0.01%
+63,721
New +$4.8M
PETQ
1221
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4.58M 0.01%
496,540
+199,828
+67% +$1.87M
PLD icon
1222
PUT
Prologis
PLD
$137B
$4.58M 0.01%
+40,600
New +$4.5M
AENT icon
1223
Alliance Entertainment
AENT
$305M
$4.57M 0.01%
449,287
DGII icon
1224
Digi International
DGII
$2.55B
$4.57M 0.01%
+125,052
New +$4.81M
CERT icon
1225
Certara
CERT
$1.21B
$4.55M 0.01%
283,407
-352,438
-55% -$5.11M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.